PLIN2 and metabolic dysfunction-associated steatotic liver disease: We therefore propose that future studies with significantly larger sample sizes and broader demographic representation are necessary to precisely clarify the relationship between serum PLIN2 levels and the full spectrum of NAFLD comorbidities.